Clinical Trials Directory

Trials / Unknown

UnknownNCT02237534

Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia

Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Osaka University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effect of lanthanum carbonate and calcium carbonate on the progression of coronary calcification and vascular endothelial dysfunction.

Conditions

Interventions

TypeNameDescription
DRUGLanthanum carbonate
DRUGCalcium Carbonate

Timeline

Start date
2014-09-01
Primary completion
2023-03-31
Completion
2023-09-01
First posted
2014-09-11
Last updated
2021-02-25

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02237534. Inclusion in this directory is not an endorsement.

Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia (NCT02237534) · Clinical Trials Directory